Compare CVS Health Corp (CVS) vs Indonesia Energy Corporation Limited (INDO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Indonesia Energy Corporation Limited — how do they compare? CVS Health Corp trades at $86.16 (market cap $112.29B), while Indonesia Energy Corporation Limited trades at $2.74 (market cap $43.24M). The key difference: CVS Health Corp is far larger — about 2596.9× Indonesia Energy Corporation Limited's market cap, and CVS Health Corp pays a 3.03% dividend while Indonesia Energy Corporation Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and Indonesia Energy Corporation Limited for 24 Days on average.
| CVS | INDO | |
|---|---|---|
Market Cap | $112.29B | $43.24M |
Volume | 7,763,676 | 116,953 |
Sector | Health | Energy |
52-Week High | $110.60 | $6.74 |
52-Week Low | $70.08 | $2.49 |
Typical Hold Time | 83 Days | 24 Days |
Enterprise Value | $174.64B | $38.18M |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, down 0.17% on the day, with a bearish technical signal and neutral oscillators. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.58 exceeding the $1.85 estimate. Revenue grew to $402.07B in 2025, though net income margin compressed to 1.18%. Recent news highlights Aetna's 2027 Medicare plan updates and a quarterly dividend declaration.
CVS presents a mixed outlook with solid revenue growth and analyst bullishness (85% buy ratings, $111.20 consensus target) offset by profitability pressures and a bearish technical trend. Key risks include reimbursement pressure and ongoing legal investigations, but the stock offers value with a low P/S of 0.27 and dividend yield support.
INDO trades at $2.74, down 1.08% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $5.10 million on $2.01 million revenue in 2025, with negative profit margins and cash flow from operations. Recent news highlights progress on the K-29 well drilling and upcoming investor presentations.
Despite a 100% buy rating from 3 analysts, INDO faces significant financial challenges with persistent losses and negative cash flow. The stock's outlook hinges on successful production from new wells, but execution risks and weak fundamentals present substantial downside potential for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Indonesia Energy Corporation Limited
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →
